[{"edinetCode":"E27032","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6754529.0,"sharesOwendPercent":0.706,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2017\/6\/29","stockCode":4584,"accountingYear":"第17期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":false,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":7212429.0,"sharesOwendPercent":0.7538,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2018\/6\/29","stockCode":4584,"accountingYear":"第18期（自　平成29年４月１日　至　平成30年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":false,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":14305487.0,"sharesOwendPercent":0.7032,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2019\/6\/28","stockCode":4584,"accountingYear":"第19期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":false,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.843,"cashAndCashEquivalents":null,"assets":3090635000.0,"currentAssets":2760926000.0,"fixedAsset":329708000.0,"tangibleFixedAssets":2112000.0,"intangibleFixedAssets":85000.0,"investmentAndOtherAssets":327510000.0,"liabilities":446426000.0,"currentLiabilities":421458000.0,"shorTermDept":25000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":24968000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":2644208000.0,"capitalStock":2620830000.0,"capital":611711000.0,"capitalSurplus":9917311000.0,"accumulatedEarnings":-7908191000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-14391000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":283959000.0,"costOfSales":76796000.0,"grossProfit":207163000.0,"sgaExpenses":416826000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":234941000.0,"operatingIncome":-209663000.0,"nonOperatingIncome":256000.0,"nonOperatingExpenses":2304000.0,"interestExpense":186000.0,"ordinaryProfit":-211711000.0,"extraordinaryGain":4419000.0,"extraordinaryLoss":5939259000.0,"incomeBeforeTax":-6146551000.0,"incomeTaxes":791000.0,"netIncome":-6147343000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-6147343000.0,"comprehensiveIncome":-6163346000.0,"eps":-222.4,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/7","stockCode":4584,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":17533996.0,"sharesOwendPercent":0.6342,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.781,"cashAndCashEquivalents":1602408000.0,"assets":2816933000.0,"currentAssets":2390099000.0,"fixedAsset":426834000.0,"tangibleFixedAssets":2032000.0,"intangibleFixedAssets":76000.0,"investmentAndOtherAssets":424725000.0,"liabilities":573271000.0,"currentLiabilities":549596000.0,"shorTermDept":25000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":23674000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":2243662000.0,"capitalStock":2217987000.0,"capital":611711000.0,"capitalSurplus":9917311000.0,"accumulatedEarnings":-8311004000.0,"treasuryStock":-31000.0,"valuationAndConversionAdjustments":-17359000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":313661000.0,"costOfSales":84500000.0,"grossProfit":229160000.0,"sgaExpenses":840471000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":484033000.0,"operatingIncome":-611310000.0,"nonOperatingIncome":358000.0,"nonOperatingExpenses":2982000.0,"interestExpense":376000.0,"ordinaryProfit":-613934000.0,"extraordinaryGain":4419000.0,"extraordinaryLoss":5939259000.0,"incomeBeforeTax":-6548774000.0,"incomeTaxes":1381000.0,"netIncome":-6550155000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-6550155000.0,"comprehensiveIncome":-6569126000.0,"eps":-236.95,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-604697000.0,"depreciationAndCashflowFromOperatingActivities":203000.0,"cashFlowFromInvestingActivities":-106258000.0,"cashFlowFromFinancialActivities":40294000.0,"changesInCashAndCashEquivalents":-670660000.0,"列1":"q2r","submitDate":"2019\/11\/13","stockCode":4584,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.507,"cashAndCashEquivalents":null,"assets":3656482000.0,"currentAssets":3238063000.0,"fixedAsset":418418000.0,"tangibleFixedAssets":1952000.0,"intangibleFixedAssets":66000.0,"investmentAndOtherAssets":416399000.0,"liabilities":1752229000.0,"currentLiabilities":528552000.0,"shorTermDept":25000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1223676000.0,"bonds":null,"convertibleBond":600000000.0,"commercialPaper":null,"longTermDebts":600000000.0,"netAsset":1904252000.0,"capitalStock":1875758000.0,"capital":611711000.0,"capitalSurplus":9917311000.0,"accumulatedEarnings":-8653190000.0,"treasuryStock":-73000.0,"valuationAndConversionAdjustments":-22622000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":733008000.0,"costOfSales":443850000.0,"grossProfit":289157000.0,"sgaExpenses":1221377000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":685251000.0,"operatingIncome":-932220000.0,"nonOperatingIncome":1444000.0,"nonOperatingExpenses":23181000.0,"interestExpense":1158000.0,"ordinaryProfit":-953957000.0,"extraordinaryGain":4419000.0,"extraordinaryLoss":5939259000.0,"incomeBeforeTax":-6888797000.0,"incomeTaxes":3545000.0,"netIncome":-6892342000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-6892342000.0,"comprehensiveIncome":-6916576000.0,"eps":-249.32,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/5","stockCode":4584,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":45.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":16175796.0,"sharesOwendPercent":0.5851,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":51.73,"equityRatio":0.398,"cashAndCashEquivalents":2032575000.0,"assets":3592139000.0,"currentAssets":3322333000.0,"fixedAsset":269805000.0,"tangibleFixedAssets":1977000.0,"intangibleFixedAssets":57000.0,"investmentAndOtherAssets":267770000.0,"liabilities":2104748000.0,"currentLiabilities":880979000.0,"shorTermDept":25000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1223768000.0,"bonds":null,"convertibleBond":600000000.0,"commercialPaper":null,"longTermDebts":600000000.0,"netAsset":1487390000.0,"capitalStock":1451704000.0,"capital":611711000.0,"capitalSurplus":9917311000.0,"accumulatedEarnings":-9077244000.0,"treasuryStock":-73000.0,"valuationAndConversionAdjustments":-21540000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":1077737000.0,"costOfSales":653158000.0,"grossProfit":424579000.0,"sgaExpenses":1585975000.0,"salaryAndBenefit":187716000.0,"depreciationAndSGA":null,"RDExpenses":898158000.0,"operatingIncome":-1161396000.0,"nonOperatingIncome":1498000.0,"nonOperatingExpenses":27355000.0,"interestExpense":5207000.0,"ordinaryProfit":-1187254000.0,"extraordinaryGain":5592000.0,"extraordinaryLoss":6132594000.0,"incomeBeforeTax":-7314255000.0,"incomeTaxes":2140000.0,"netIncome":-7316396000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-7316396000.0,"comprehensiveIncome":-7339548000.0,"eps":-264.65,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1325059000.0,"depreciationAndCashflowFromOperatingActivities":382000.0,"cashFlowFromInvestingActivities":-137206000.0,"cashFlowFromFinancialActivities":1221771000.0,"changesInCashAndCashEquivalents":-240494000.0,"列1":"asr","submitDate":"2020\/7\/17","stockCode":4584,"accountingYear":"第20期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.437,"cashAndCashEquivalents":null,"assets":3951997000.0,"currentAssets":3573101000.0,"fixedAsset":378896000.0,"tangibleFixedAssets":1894000.0,"intangibleFixedAssets":3138000.0,"investmentAndOtherAssets":373862000.0,"liabilities":2156095000.0,"currentLiabilities":772482000.0,"shorTermDept":25000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1383613000.0,"bonds":null,"convertibleBond":740000000.0,"commercialPaper":null,"longTermDebts":600000000.0,"netAsset":1795902000.0,"capitalStock":1666847000.0,"capital":841711000.0,"capitalSurplus":10147311000.0,"accumulatedEarnings":-9322101000.0,"treasuryStock":-73000.0,"valuationAndConversionAdjustments":58771000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":121294000.0,"costOfSales":4971000.0,"grossProfit":116322000.0,"sgaExpenses":354080000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":138411000.0,"operatingIncome":-237757000.0,"nonOperatingIncome":391000.0,"nonOperatingExpenses":6975000.0,"interestExpense":4052000.0,"ordinaryProfit":-244341000.0,"extraordinaryGain":null,"extraordinaryLoss":0.0,"incomeBeforeTax":-244341000.0,"incomeTaxes":515000.0,"netIncome":-244857000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-244857000.0,"comprehensiveIncome":-164545000.0,"eps":-8.72,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/14","stockCode":4584,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":16370773.0,"sharesOwendPercent":0.5652,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.383,"cashAndCashEquivalents":2501566000.0,"assets":3611455000.0,"currentAssets":3218008000.0,"fixedAsset":393446000.0,"tangibleFixedAssets":1810000.0,"intangibleFixedAssets":2966000.0,"investmentAndOtherAssets":388669000.0,"liabilities":2144975000.0,"currentLiabilities":857914000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1287061000.0,"bonds":null,"convertibleBond":640000000.0,"commercialPaper":null,"longTermDebts":600000000.0,"netAsset":1466479000.0,"capitalStock":1315624000.0,"capital":891711000.0,"capitalSurplus":10197311000.0,"accumulatedEarnings":-9773324000.0,"treasuryStock":-73000.0,"valuationAndConversionAdjustments":69075000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":174487000.0,"costOfSales":39964000.0,"grossProfit":134523000.0,"sgaExpenses":817249000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":403208000.0,"operatingIncome":-682725000.0,"nonOperatingIncome":809000.0,"nonOperatingExpenses":11682000.0,"interestExpense":7985000.0,"ordinaryProfit":-693599000.0,"extraordinaryGain":null,"extraordinaryLoss":1449000.0,"incomeBeforeTax":-695048000.0,"incomeTaxes":1031000.0,"netIncome":-696079000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-696079000.0,"comprehensiveIncome":-605464000.0,"eps":-24.49,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-104638000.0,"depreciationAndCashflowFromOperatingActivities":561000.0,"cashFlowFromInvestingActivities":-5854000.0,"cashFlowFromFinancialActivities":579484000.0,"changesInCashAndCashEquivalents":468991000.0,"列1":"q2r","submitDate":"2020\/11\/11","stockCode":4584,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.385,"cashAndCashEquivalents":null,"assets":3669650000.0,"currentAssets":3329488000.0,"fixedAsset":340161000.0,"tangibleFixedAssets":1726000.0,"intangibleFixedAssets":2794000.0,"investmentAndOtherAssets":335640000.0,"liabilities":2156039000.0,"currentLiabilities":925324000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1230715000.0,"bonds":null,"convertibleBond":600000000.0,"commercialPaper":null,"longTermDebts":600000000.0,"netAsset":1513611000.0,"capitalStock":1380806000.0,"capital":911711000.0,"capitalSurplus":10217311000.0,"accumulatedEarnings":-9748142000.0,"treasuryStock":-73000.0,"valuationAndConversionAdjustments":32001000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":720859000.0,"costOfSales":86186000.0,"grossProfit":634673000.0,"sgaExpenses":1282078000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":600660000.0,"operatingIncome":-647405000.0,"nonOperatingIncome":2245000.0,"nonOperatingExpenses":15818000.0,"interestExpense":11868000.0,"ordinaryProfit":-660977000.0,"extraordinaryGain":null,"extraordinaryLoss":8513000.0,"incomeBeforeTax":-669491000.0,"incomeTaxes":1406000.0,"netIncome":-670897000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-670897000.0,"comprehensiveIncome":-617356000.0,"eps":-23.43,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/10","stockCode":4584,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":39.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":16550370.0,"sharesOwendPercent":0.5587,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":50.44,"equityRatio":0.38,"cashAndCashEquivalents":1461158000.0,"assets":3933952000.0,"currentAssets":3346310000.0,"fixedAsset":587641000.0,"tangibleFixedAssets":3223000.0,"intangibleFixedAssets":2622000.0,"investmentAndOtherAssets":581795000.0,"liabilities":2323566000.0,"currentLiabilities":1114319000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1209246000.0,"bonds":null,"convertibleBond":500000000.0,"commercialPaper":null,"longTermDebts":600000000.0,"netAsset":1610385000.0,"capitalStock":1291179000.0,"capital":1032179000.0,"capitalSurplus":10337779000.0,"accumulatedEarnings":-10078706000.0,"treasuryStock":-73000.0,"valuationAndConversionAdjustments":202965000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":996543000.0,"costOfSales":119571000.0,"grossProfit":876971000.0,"sgaExpenses":1846659000.0,"salaryAndBenefit":246723000.0,"depreciationAndSGA":null,"RDExpenses":963868000.0,"operatingIncome":-969687000.0,"nonOperatingIncome":2552000.0,"nonOperatingExpenses":24031000.0,"interestExpense":15688000.0,"ordinaryProfit":-991166000.0,"extraordinaryGain":null,"extraordinaryLoss":8513000.0,"incomeBeforeTax":-999680000.0,"incomeTaxes":1781000.0,"netIncome":-1001461000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1001461000.0,"comprehensiveIncome":-776955000.0,"eps":-34.79,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1267471000.0,"depreciationAndCashflowFromOperatingActivities":992000.0,"cashFlowFromInvestingActivities":-22290000.0,"cashFlowFromFinancialActivities":718345000.0,"changesInCashAndCashEquivalents":-571417000.0,"列1":"asr","submitDate":"2021\/6\/30","stockCode":4584,"accountingYear":"第21期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.43,"cashAndCashEquivalents":null,"assets":3521678000.0,"currentAssets":2794146000.0,"fixedAsset":727532000.0,"tangibleFixedAssets":2824000.0,"intangibleFixedAssets":2450000.0,"investmentAndOtherAssets":722258000.0,"liabilities":1873492000.0,"currentLiabilities":822941000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1050550000.0,"bonds":null,"convertibleBond":300000000.0,"commercialPaper":null,"longTermDebts":600000000.0,"netAsset":1648186000.0,"capitalStock":1213350000.0,"capital":1150275000.0,"capitalSurplus":10455876000.0,"accumulatedEarnings":-10392728000.0,"treasuryStock":-73000.0,"valuationAndConversionAdjustments":300519000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":303367000.0,"costOfSales":121792000.0,"grossProfit":181574000.0,"sgaExpenses":490802000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":296718000.0,"operatingIncome":-309227000.0,"nonOperatingIncome":1530000.0,"nonOperatingExpenses":5949000.0,"interestExpense":3882000.0,"ordinaryProfit":-313646000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-313646000.0,"incomeTaxes":375000.0,"netIncome":-314021000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-314021000.0,"comprehensiveIncome":-216467000.0,"eps":-10.5,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/13","stockCode":4584,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":17147522.0,"sharesOwendPercent":0.5455,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.48,"cashAndCashEquivalents":974242000.0,"assets":3859062000.0,"currentAssets":3203440000.0,"fixedAsset":655622000.0,"tangibleFixedAssets":2425000.0,"intangibleFixedAssets":2277000.0,"investmentAndOtherAssets":650919000.0,"liabilities":1860343000.0,"currentLiabilities":1034080000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":826263000.0,"bonds":null,"convertibleBond":100000000.0,"commercialPaper":null,"longTermDebts":600000000.0,"netAsset":1998718000.0,"capitalStock":1602713000.0,"capital":1419557000.0,"capitalSurplus":10725157000.0,"accumulatedEarnings":-10541928000.0,"treasuryStock":-73000.0,"valuationAndConversionAdjustments":251220000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":740635000.0,"costOfSales":275700000.0,"grossProfit":464935000.0,"sgaExpenses":915868000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":532689000.0,"operatingIncome":-450932000.0,"nonOperatingIncome":1704000.0,"nonOperatingExpenses":14387000.0,"interestExpense":7761000.0,"ordinaryProfit":-463616000.0,"extraordinaryGain":1144000.0,"extraordinaryLoss":null,"incomeBeforeTax":-462471000.0,"incomeTaxes":750000.0,"netIncome":-463221000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-463221000.0,"comprehensiveIncome":-414966000.0,"eps":-15.3,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-857808000.0,"depreciationAndCashflowFromOperatingActivities":1143000.0,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":370892000.0,"changesInCashAndCashEquivalents":-486916000.0,"列1":"q2r","submitDate":"2021\/11\/10","stockCode":4584,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0},{"edinetCode":"E27032","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.506,"cashAndCashEquivalents":null,"assets":3900557000.0,"currentAssets":3722479000.0,"fixedAsset":178077000.0,"tangibleFixedAssets":2025000.0,"intangibleFixedAssets":3255000.0,"investmentAndOtherAssets":172795000.0,"liabilities":1762684000.0,"currentLiabilities":1044579000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":718105000.0,"bonds":null,"convertibleBond":100000000.0,"commercialPaper":null,"longTermDebts":600000000.0,"netAsset":2137872000.0,"capitalStock":1972479000.0,"capital":1420030000.0,"capitalSurplus":10725630000.0,"accumulatedEarnings":-10173107000.0,"treasuryStock":-73000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":1383239000.0,"costOfSales":458501000.0,"grossProfit":924737000.0,"sgaExpenses":1357696000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":770421000.0,"operatingIncome":-432958000.0,"nonOperatingIncome":1704000.0,"nonOperatingExpenses":28792000.0,"interestExpense":11653000.0,"ordinaryProfit":-460046000.0,"extraordinaryGain":418881000.0,"extraordinaryLoss":null,"incomeBeforeTax":-41165000.0,"incomeTaxes":53236000.0,"netIncome":-94401000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-94401000.0,"comprehensiveIncome":-297367000.0,"eps":-3.08,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/14","stockCode":4584,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27032","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":611,"settlementDate":"2022\/3\/31","submitterName":"株式会社ジーンテクノサイエンス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャジーンテクノサイエンス","location":"中央区新川一丁目２番１２号","industory":"医薬品","corporateNumber":5430000000000.0}]